‘Amazing’ trial shows drug combination stops lung cancer advancing for longer Posted by Paul Battista in biotech/medical Oct 52024 Exclusive: Global trial finds treatment with amivantamab and lazertinib halts progression for average of 23.7 months. Read more | >
